Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Aseafan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cureus|November 16, 2022
Thyroid Abscess in a Young Postpartum FemaleSultan Almdallaleh, Mohamed Aseafan, Latif Khan
Cureus|June 27, 2022
Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case ReportAli Alhanash, Mohamed Aseafan, Jean Atallah
Scientific Reports|January 8, 2022
Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009Mohamed Aseafan, Edward Devol, Mahmoud AlAhwal, et al.
Hematology/Oncology and Stem Cell Therapy|March 18, 2026
Characteristic and Clinical Outcomes of Localized Gastric Cancer: A Real-World ExperienceAmal Aljuhani, Mohamed Aseafan, Ali Sheikh, et al.
World Journal of Clinical Cases|April 18, 2022
Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapyShouki Bazarbashi, Abdulrahman Alghabban, Mohamed Aseafan, et al.
Molecular and Clinical Oncology|February 17, 2023
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi ArabiaBader Alshamsan, Mohamed Aseafan, Ahmed Badran, et al.
Cureus|February 21, 2024
Phase II Trial of FOLFIRINOX in Advanced Biliary Tract CancerShouki Bazarbashi, Mohamed Aseafan, Mahmoud Elshenawy, et al.
Cureus|August 31, 2022
Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center ExperienceMohamed Aseafan, Ahmed Mostafa Gad, Bader Alshamsan, et al.
Journal of Hepatocellular Carcinoma|January 5, 2026
Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021Edward B De Vol, Shouki Bazarbashi, Mohamed Aseafan, et al.
JCO Global Oncology|March 14, 2024
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative StudyShouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cureus|November 16, 2022
Thyroid Abscess in a Young Postpartum FemaleSultan Almdallaleh, Mohamed Aseafan, Latif Khan
Cureus|June 27, 2022
Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case ReportAli Alhanash, Mohamed Aseafan, Jean Atallah
Scientific Reports|January 8, 2022
Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009Mohamed Aseafan, Edward Devol, Mahmoud AlAhwal, et al.
Hematology/Oncology and Stem Cell Therapy|March 18, 2026
Characteristic and Clinical Outcomes of Localized Gastric Cancer: A Real-World ExperienceAmal Aljuhani, Mohamed Aseafan, Ali Sheikh, et al.
World Journal of Clinical Cases|April 18, 2022
Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapyShouki Bazarbashi, Abdulrahman Alghabban, Mohamed Aseafan, et al.
Molecular and Clinical Oncology|February 17, 2023
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi ArabiaBader Alshamsan, Mohamed Aseafan, Ahmed Badran, et al.
Cureus|February 21, 2024
Phase II Trial of FOLFIRINOX in Advanced Biliary Tract CancerShouki Bazarbashi, Mohamed Aseafan, Mahmoud Elshenawy, et al.
Cureus|August 31, 2022
Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center ExperienceMohamed Aseafan, Ahmed Mostafa Gad, Bader Alshamsan, et al.
Journal of Hepatocellular Carcinoma|January 5, 2026
Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021Edward B De Vol, Shouki Bazarbashi, Mohamed Aseafan, et al.
JCO Global Oncology|March 14, 2024
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative StudyShouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, et al.
Pageof 2